Login

Marnix van Stiphout, COO of ING, discusses the impact of artificial intelligence and digitalization on the banking sector. 00:10:00

Share On Facebook Share On Twitter

Steven van Rijswijk, CEO of ING

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Consensus on Risk-On Strategy: Cyclicals and Financials in Focus
00:10:00
Anaconda Mining: From Newfoundland Gold Production to Nova Scotia's Goldboro Project - Aiming for Mid-Tier Status
00:10:00
Meri Grogan: Syverson Strege Team | Meri Grogan - Director of Finance & Administration of Syverson Strege
00:10:00
Winter 2024: Market Recap and Future Insights | Dmitriy Katsnelson, Investment Team, Wealthspire Advisors and Chris Maxey, Investment Team, Wealthspire Advisors
00:10:00
Vow ASA CEO Henrik Badin and Ex-Microsoft CTO Shahzad Rana Address Climate Crisis on The Vow Pod | Henrik Badin, CEO, Vow ASA.
00:10:00
Help the ambitious founders who actively seek to change the status quo|Adam Valkin,Managing Director,General Catalyst
00:10:00
Dan Bar-Holden Highlights Luca Mining's Strong Q2 Performance and Future Growth Plans
00:10:00
Integrating ESOPs into Your Retirement Plan: Insights with Scott Sturgeon | Scott Sturgeon, Founder, Oread Wealth Partners.
00:10:00
An overview of Kape (formerly Crossrider) provided by CEO Ido Erlichman, offering strategic insights before the game-changing acquisition of LTMI Holdings| Ido Erlichman CEO of Kape technology ltd
00:10:00
Panther Metals Ltd. Leadership on ASX Listing and Exploration Targets | Dan Tuffin, CEO, Panther Metals Ltd.
00:10:00
Chris Lee on Job Growth from Ports America's Investment in the Port of Oakland
00:10:00
Filament Health and Reset Pharmaceuticals Strike Licensing Deal for Psilocybin Drug PEX010 | Benjamin Lightburn, CEO , Filament Health Corp.

© 2026 Nehu